Static Chart StemRIM

Stocks

Market Closed - Japan Exchange 10:30:00 30/09/2026 +04			5-day change	1st Jan Change
170.00 ^JPY	+2.41%		-3.95%	-35.36%

09-25	StemRIM Inc. Announces Patent Registration In South Korea For Use Of Redasemtide As Additional Therapeutic Indication Of Cartilage Disorders	CI
09-09	StemRIM Reports Earnings Results for the Full Year Ended July 31, 2026	CI

Duration

Period